Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. Among authors: legat fj. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, Bieber T, Misery L, Wollenberg A, Reich A, Ahmad F, Piketty C. Ständer S, et al. Among authors: legat fj. N Engl J Med. 2020 Feb 20;382(8):706-716. doi: 10.1056/NEJMoa1908316. N Engl J Med. 2020. PMID: 32074418 Clinical Trial.
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase.
Weisshaar E, Szepietowski JC, Bernhard JD, Hait H, Legat FJ, Nattkemper L, Reich A, Sadoghi B, Sciascia TR, Zeidler C, Yosipovitch G, Ständer S. Weisshaar E, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):453-461. doi: 10.1111/jdv.17816. Epub 2021 Dec 1. J Eur Acad Dermatol Venereol. 2022. PMID: 34780095 Clinical Trial.
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
Yosipovitch G, Lio P, Legat FJ, Chovatiya R, Deleuran M, Pierce E, Casillas M, Ding Y, Yang FE, Bardolet L, Ständer S. Yosipovitch G, et al. Among authors: legat fj. Dermatol Ther (Heidelb). 2024 Aug;14(8):2171-2180. doi: 10.1007/s13555-024-01225-w. Epub 2024 Jul 13. Dermatol Ther (Heidelb). 2024. PMID: 39002092 Free PMC article.
Chronic prurigo: Insufficient disease control in spite of high healthcare usage.
Pereira MP, Weisshaar E, Halvorsen JA, Wallengren J, Legat FJ, Garcovich S, Savk E, Reich A, Bozek A, Lvov A, Bobko S, Metz M, Streit M, Misery L, Brenaut E, Serra-Baldrich E, Gonçalo M, Szepietowski JC, Augustin M, Nau T, Zeidler C, Ständer S. Pereira MP, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e808-e812. doi: 10.1111/jdv.18903. Epub 2023 Feb 21. J Eur Acad Dermatol Venereol. 2023. PMID: 36682045 No abstract available.
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S, Pereira MP, Zeidler C, Legat FJ, Misery L, Lönndahl L, Bewley AP, Brenaut E, Bobko S, Elberling J, Evers AWM, Garcovich S, Gieler U, Gonçalo M, Kupfer J, Lambert J, Lvov A, Metz M, Michenko A, Papadavid E, Reich A, Savk E, Schneider G, Schut C, Serra-Baldrich E, Ständer HF, Szepietowski JC, Wallengren J, Weisshaar E, Augustin M. Ständer S, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1687-1693. doi: 10.1111/jdv.20102. Epub 2024 May 13. J Eur Acad Dermatol Venereol. 2024. PMID: 38738586
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.
Pereira MP, Steinke S, Zeidler C, Forner C, Riepe C, Augustin M, Bobko S, Dalgard F, Elberling J, Garcovich S, Gieler U, Gonçalo M, Halvorsen JA, Leslie TA, Metz M, Reich A, Şavk E, Schneider G, Serra-Baldrich E, Ständer HF, Streit M, Wallengren J, Weller K, Wollenberg A, Bruland P, Soto-Rey I, Storck M, Dugas M, Weisshaar E, Szepietowski JC, Legat FJ, Ständer S; EADV Task Force Pruritus group members. Pereira MP, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1059-1065. doi: 10.1111/jdv.14570. Epub 2017 Sep 22. J Eur Acad Dermatol Venereol. 2018. PMID: 28857299
S2k guideline: Diagnosis and treatment of chronic pruritus.
Ständer S, Zeidler C, Augustin M, Darsow U, Kremer AE, Legat FJ, Koschmieder S, Kupfer J, Mettang T, Metz M, Nast A, Raap U, Schneider G, Ständer H, Streit M, Schut C, Weisshaar E. Ständer S, et al. Among authors: legat fj. J Dtsch Dermatol Ges. 2022 Oct;20(10):1387-1402. doi: 10.1111/ddg.14830. J Dtsch Dermatol Ges. 2022. PMID: 36252071 Free article.
95 results